ALB and congenital secretory chloride diarrhea 1: Stem cell therapy was associated with more improved liver functions in the CLD without ACLF subgroup, as indicated by decreased MELD scores, decreased TBIL levels, and increased ALB levels at weeks 4, 12, and 24.